Ceradyne, Inc. (Nasdaq: CRDN) has been awarded a $342,000 research phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE